The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
ONLY
ARTICLE
August 19, 2024
Ganaxolone (Ztalmy) for CDKL5 Deficiency Disorder (online only)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Ganaxolone (Ztalmy) for CDKL5 Deficiency Disorder (online only)
August 19, 2024 (Issue: 1709)
The FDA has approved ganaxolone (Ztalmy – Marinus)
for oral treatment of seizures associated with cyclin-dependent
kinase-like 5 (CDKL5) deficiency disorder
in patients ≥2 years old. It is the first drug to be
approved in the US for this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.